Latest data from May 6, 2022
Number of Health Center respondents = 60 (83% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics | Value |
---|---|
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 5,477 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 85.34% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 210 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 77.78% |
Patients by Race and Ethnicity
Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
---|---|---|
White, Non-Hispanic/Latino Patients | 13.13% | 20.00% |
White, Hispanic/Latino Patients | 60.25% | 56.19% |
Black/African American, Non-Hispanic/Latino Patients | 6.45% | 7.62% |
Black/African American, Hispanic/Latino Patients | 0.62% | 0.00% |
Asian Patients3 | 1.21% | 0.95% |
American Indian/Alaska Native Patients3 | 0.38% | 0.00% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.26% | 0.48% |
Patients with More Than One Race3 | 2.10% | 0.95% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.19% | 3.81% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.39% | 0.48% |
Unreported/Refused to Report Race and Ethnicity | 9.04% | 9.52% |
Patients Vaccinated
Metrics | Value |
---|---|
COVID-19 Immunization Series Initiated | 661 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 90.43% |
COVID-19 Immunization Series Completed | 661 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 91.97% |
COVID-19 Immunization Series Additional | 1,613 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 87.52% |
Vaccinations by Race and Ethnicity
Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
---|---|---|---|
White, Non-Hispanic/Latino Patients | 9.08% | 7.41% | 12.09% |
White, Hispanic/Latino Patients | 67.17% | 64.75% | 64.41% |
Black/African American, Non-Hispanic/Latino Patients | 7.72% | 7.72% | 7.07% |
Black/African American, Hispanic/Latino Patients | 1.51% | 0.76% | 0.56% |
Asian Patients3 | 1.36% | 1.66% | 1.49% |
American Indian/Alaska Native Patients3 | 0.45% | 0.15% | 2.67% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 0.15% | 0.19% |
Patients with More Than One Race3 | 1.51% | 0.91% | 0.37% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.05% | 8.77% | 8.00% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.82% | 1.21% | 0.74% |
Unreported/Refused to Report Race and Ethnicity | 3.33% | 6.51% | 2.42% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics | Value |
---|---|
Less Than 1 Hour | 35.00% |
1 to 24 Hours | 35.00% |
More Than 24 Hours | 28.33% |
N/A | 1.67% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics | Value |
---|---|
Financial reimbursement for costs associated with vaccine administration | 10.00% |
Staffing to administer the vaccine | 18.33% |
Vaccine confidence | 25.00% |
Vaccine storage capacity | 5.00% |
Vaccine supply | 1.67% |
Other | 11.67% |
None | 45.00% |
Operations and Staff
Metrics | Value |
---|---|
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 33.33% |
Average Percent of Health Center Visits Conducted Virtually | 12.00% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics | Value |
---|---|
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 26.67% |
Number of Mobile Van Sites | 7 |
Number of Pop-up Clinics | 3 |
Number of School-Based Vaccination Sites | 5 |
Number of Family Vaccination Clinics | 36 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Direct provision of monoclonal antibody therapies | 1.67% |
Refer patients to another organization that provides monoclonal antibody therapies | 60.00% |
None | 38.33% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Access to therapeutics | 13.33% |
Patient awareness/education | 3.33% |
Staffing capacity | 21.67% |
Therapy administration/onsite logistics | 18.33% |
Other | 5.00% |
None | 61.67% |
Test Kit Distribution
Metrics | Value |
---|---|
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 33 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 54,682 |
Test Kit Distribution Methods4
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 75.76% |
Provided to General Public Who Came to the Health Center | 51.52% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 24.24% |
Provided at Other Community Events | 27.27% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 9.09% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 24.24% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 15.15% |
Provided to school-age children and/or their families directly or through partnerships with schools | 18.18% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 18.18% |
Other | 3.03% |
N95 Mask Distribution
Metrics | Value |
---|---|
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 19 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 29,819 |
N95 Mask Distribution Methods5
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 89.47% |
Provided to General Public Who Came to the Health Center | 42.11% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 26.32% |
Provided at Other Community Events | 26.32% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 15.79% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 31.58% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 31.58% |
Provided to school-age children and/or their families directly or through partnerships with schools | 21.05% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 26.32% |
Other | 5.26% |
Oral Antiviral Medication Distribution
Metrics | Value |
---|---|
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 8 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 95.12% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity | Value |
---|---|
White, Non-Hispanic/Latino Patients | 0.00% |
White, Hispanic/Latino Patients | 82.93% |
Black/African American, Non-Hispanic/Latino Patients | 0.00% |
Black/African American, Hispanic/Latino Patients | 0.00% |
Asian Patients3 | 0.00% |
American Indian/Alaska Native Patients3 | 2.44% |
Native Hawaiian/Other Pacific Islander Patients3 | 2.44% |
Patients with More Than One Race3 | 0.00% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 7.32% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
Unreported/Refused to Report Race and Ethnicity | 4.88% |
Oral Antiviral Medication Distribution by Population Type
Metrics | Value |
---|---|
Migratory/Agricultural Workers | 0.00% |
Patients Experiencing Homelessness | 0.00% |
Patients Who Are Residents of Public Housing | 4.88% |
Patients with Limited English Proficiency | 17.07% |
Children Under 18 Years of Age | 2.44% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.